Cargando…
Any progress in informed consenting for cancer treatment? Results from a cross sectional analysis at a comprehensive cancer center
PURPOSE: Informed consent is required prior to any medical procedure. In the context of cancer treatment, special efforts are needed to inform cancer patients properly about treatment, potential sequelae and alternative therapies. Little is known about the effectiveness of current informed consent s...
Autores principales: | Schwaegermann, Marie-Kristin, Schranz, Melanie, Moehler, Markus, Labenz, Christian, Moringlane, Alice, Schmidt, Marcus, Theobald, Matthias, Hess, Georg |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8164598/ https://www.ncbi.nlm.nih.gov/pubmed/33420813 http://dx.doi.org/10.1007/s00432-020-03495-1 |
Ejemplares similares
-
Struggling with extensive informed consent procedures for cancer trials—is there even a benefit for the patients?
por: Tilch, Marie-Kristin, et al.
Publicado: (2022) -
Targeting PI3K in Cancer: Any Good News?
por: Martini, Miriam, et al.
Publicado: (2013) -
PARP Inhibitors in First-Line Therapy of Ovarian Cancer: Are There Any Doubts?
por: Franzese, Elisena, et al.
Publicado: (2020) -
Study protocol for a randomised controlled trial of enhanced informed consent compared to standard informed consent to improve patient understanding of early phase oncology clinical trials (CONSENT)
por: Pal, Abhijit, et al.
Publicado: (2021) -
Rational Combination of Parvovirus H1 With CTLA-4 and PD-1 Checkpoint Inhibitors Dampens the Tumor Induced Immune Silencing
por: Goepfert, Katrin, et al.
Publicado: (2019)